Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43Lung Neoplasms 29Neoplasms 25Colorectal Neoplasms 19Prostatic Neoplasms 12Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Anxiety Disorders 8Neoplasm Metastasis 7Hematopoietic and Lymphatic System Neoplasm 7Lymphoma 6Papillomavirus Infections 5Ovarian Neoplasms 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Depression 5Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Skin Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Malignant Solid Neoplasm 3

Interventions

Resistance Training 3Nutritional Status 2Resistant Starch 1Plant Proteins 1Nutrition Assessment 1Methods 1Exercise Movement Techniques 1Exercise 1Ethanol 1Endodontics 1Educational Status 1Early Intervention, Educational 1Diet 1Continuous Glucose Monitoring 1Circuit-Based Exercise 1Cholecalciferol 1Blood Specimen Collection 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Diabetes Mellitus, Type 2 × Educational Status × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡